ICP Parking Lot/Vaccines: Difference between revisions

From Commons Based Research
Jump to navigation Jump to search
Line 1: Line 1:
{{TOCright}}
{{TOCright}}
=[[Vaccines/Bibliography|Bibliography]]=
=[[Vaccines/Bibliography|Bibliography]]=
*'''American Society of Law, Medicine & Ethics, Inc., and Boston University American Journal of Law & Medicine, 2009, 35 Am. J. L. and Med.:'''
* 2009, 35 Am. J. L. and Med.
** [[Vaccines/Bibliography/35 Am. J. L. and Med.|Highlights]]
** [[Vaccines/Bibliography/35 Am. J. L. and Med.|Highlights]]
* 'Follow-On Biologics: Intellectual Property and Innovation Issues (2009) Available at: http://www.bio.org/healthcare/followon/ and @www.biosimilars.com/CRS_FOBs.pdf  
* 'Follow-On Biologics: Intellectual Property and Innovation Issues (2009) Available at: http://www.bio.org/healthcare/followon/ and @www.biosimilars.com/CRS_FOBs.pdf  
* Emerging Health Care Issues: Follow-on Biologic Drug Competition. (2009) Available at:  www.ftc.gov/os/2009/06/P083901biologicsreport.pdf
* Emerging Health Care Issues: Follow-on Biologic Drug Competition. (2009) Available at:  www.ftc.gov/os/2009/06/P083901biologicsreport.pdf
*  Intellectual Property Watch, 2010. Biotech Marathon: Vaccines And Open Innovation, But Less IP? Available at: http://www.ip-watch.org/weblog/2010/02/16/biotech-marathon-vaccines-and-open-innovation-but-less-ip/.
*  Intellectual Property Watch, 2010. Biotech Marathon: Vaccines And Open Innovation, But Less IP? Available at: http://www.ip-watch.org/weblog/2010/02/16/biotech-marathon-vaccines-and-open-innovation-but-less-ip/.
* LUDWIG,STEVEN R. (2009) Data Exclusivity – A Necessary Form of Intellectual Property. Available at: www.iptoday.com/pdf/2007/8/Ludwig-Aug2007.pdf


=Navigation=
=Navigation=
Back to [[Main Page]]
Back to [[Main Page]]
Back to [[Biotechnology_-_Genomic_and_Proteomics]]
Back to [[Biotechnology_-_Genomic_and_Proteomics]]

Revision as of 20:56, 5 May 2010

Bibliography

Navigation

Back to Main Page Back to Biotechnology_-_Genomic_and_Proteomics